Many Honored On Veterans Day In NYC WNBC
NEW YORK -- Veterans Day was observed on Friday with the dedication of a World War II memorial in Queens and an war protest in Manhattan. U.S. veterans were present at many of the events held in New York City in honor of the national holiday, which is officially observed Saurday.
Veterans Day Hailed With WW2 Memorial, War Protest CBS 2 New York
Veterans Day was observed today with the dedication of a World War II memorial in Queens and an anti-war protest in Manhattan. U.S. veterans were present at many of the events held in New York City in honor of the national holiday, which is officially observed tomorrow. A Veterans Day parade is scheduled to begin at 11 a.m. tomorrow on Fifth Avenue in midtown Manhattan.
Veterans Day Parade WABC-TV New York
It's Veterans Day, a time when Americans honor those who have served the country during wartime.
Protherics PLC - Research Update RedNova
Protherics PLC
Protherics PLC - Research Update Market Wire via Yahoo! Finance
London, UK; Brentwood, TN, US; 7 November 2006 - Protherics PLC, the international biopharmaceutical company focused on critical care and cancer, today announces that following the submission of the Biologicals License Application for Voraxaze(TM) to the Food and Drug Administration in the US on 15 September 2006, the FDA has requested additional manufacturing data. As a result, Protherics has
Protherics PLC and AstraZeneca Updates CytoFabTM Development Programme SYS-CON Media
London, UK; Brentwood, TN, US; 3 November 2006 - Protherics PLC ("Protherics" or the "Company") and AstraZeneca today announce AstraZeneca's intention to expand the development plan for CytoFab(TM), a treatment for severe sepsis, with the addition of a 480 - patient Phase II study programme.
Protherics PLC and AstraZeneca Updates CytoFabTM Development Programme RedNova
Protheri
Uusimmat | Kauppalehti Online Kauppalehti Online
Provided by Observer ASTRAZENECA UPDATES CYTOFABTM DEVELOPMENT PROGRAMME AstraZeneca today announced its intention to expand the development plan for CytoFabTM, a treatment for severe sepsis, with the addition of a 480 - patient Phase II study programme.
CAS Medical Systems, Inc. Reports Record Third Quarter Results PR Newswire via Yahoo! Finance
CAS Medical Systems, Inc. today announced record financial results for the third quarter and nine months ended September 30, 2006.
CAS Medical Systems, Inc. to Present at the C.E. Unterberg, Towbin Life Sciences Conference SYS-CON Media
CAS Medical Systems, Inc. , a medical device company focused on innovative non-invasive vital signs monitoring, announced today that Andrew Kersey, Chief Operating Officer and Jeffery Baird, Chief Financial Officer will be presenting an overview of the Company at the C.E. Unterberg, Towbin Life Sciences Conference in New York City, Monday, October 30, 2006 at 2:30 pm Eastern Time. The conference